Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Real-World Experience of Pola-R-CHP Therapy in Diffuse Large B-Cell Lymphoma Aged 80 or Older

Nobuhiro Kanemura, Toshiki Yamada, Hideko Goto, Takeshi Hara, Senji Kasahara, Kenji Fukuno, Michio Sawada, Hiroshi Nakamura, Nobuhiko Nakamura, Shin Lee, Kei Fujita, Tomomi Suzaki, Naoki Hayase, Takayuki Goto, Masahito Shimizu, Hisashi Tsurumi

Blood (2024) 144 (Supplement 1): 3089.

https://doi.org/10.1182/blood-2024-200404

Published: 2024

Journal Articles

Prognostic Impact of Skeletal Muscle Index and Vitamin D in Diffuse Large B-Cell Lymphoma

Nobuhiko Nakamura, Nobuhiro Kanemura, Ryoma Shimazu, Takayuki Goto, Yuto Kaneda, Yoshikazu Ikoma, Takuro Matsumoto, Hiroshi Nakamura, Masahito Shimizu

Blood (2023) 142 (Supplement 1): 3109.

https://doi.org/10.1182/blood-2023-178152

Published: 2023

Journal Articles

The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Elderly Patients with Diffuse Large B-Cell Lymphoma

Yuto Kaneda, MD, Nobuhiro Kanemura, MD PhD, Nobuhiko Nakamura, MD PhD, Yoshikazu Ikoma, MD, Kimihiro Yamaguchi, MD, Takuro Matsumoto, MD PhD, Yuhei Shibata, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Senji Kasahara, MD PhD, Takeshi Hara, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2018) 132 (Supplement 1): 4210.

https://doi.org/10.1182/blood-2018-99-110055

Published: 2018

Journal Articles

Prospective PhaseⅡ Study of Reduced Toxicity Conditioning Consisted of High Dose-Cytarabine, Fludarabine, Cyclophosphamide +/- Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation

Senji Kasahara, MD PhD, Hiroshi Nakamura, MD, Yuto Kaneda, MD, Yoshikazu Ikoma, MD, Eri Takada, MD, Kimihiro Yamaguchi, MD, Yuhei Shibata, MD PhD, Takuro Matsumoto, MDPhD, Nobuhiko Nakamura, MD PhD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Hideko Goto, MD PhD, Takeshi Hara, MD PhD, Michio Sawada, MD PhD, Takeshi Takahashi, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD

Blood (2017) 130 (Supplement 1): 1960.

https://doi.org/10.1182/blood.V130.Suppl_1.1960.1960

Published: 2017

Journal Articles

The Roles of Aryl Hydrocarbon Receptor in T Cells at IDO-Positive Tumor Microenvironment

Soranobu Ninomiya, MD PhD, Nobuhiko Nakamura, MD PhD, Junichi Kitagawa, MD PhD, Takeshi Hara, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2016) 128 (22): 3693.

https://doi.org/10.1182/blood.V128.22.3693.3693

Published: 2016

Journal Articles

Benefit of Consolidative Radiotherapy in Patients with Limited Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era

Nobuhiko Nakamura, MD PhD, Yoshikazu Ikoma, MD, Yuhei Shibata, MD PhD, Takuro Matsumoto, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2016) 128 (22): 4210.

https://doi.org/10.1182/blood.V128.22.4210.4210

Published: 2016

Journal Articles

The Value of Combination of Serum L-Kynurenine Level and Expression of Indoleamine 2,3-Dioxygenase mRNA As a Prognostic Factor in Acute Myeloid Leukemia

Hisashi Tsurumi, MD PhD, Takuro Matsumoto, MD, Yuhei Shibata, MD, Nobuhiko Nakamura, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD

Blood (2015) 126 (23): 4947.

https://doi.org/10.1182/blood.V126.23.4947.4947

Published: 2015

Journal Articles

Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia

Nobuhiko Nakamura, MD PhD, Yuhei Shibata, MD, Takuro Matsumoto, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD PhD, Soranobu Ninomiya, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2015) 126 (23): 4953.

https://doi.org/10.1182/blood.V126.23.4953.4953

Published: 2015

Journal Articles

The Incidence and the Risk Factors of Bowel Perforation Due to Chemotherapy in Gastrointestinal Diffuse Large B Cell Lymphoma

Takuro Matsumoto, MD, Yuhei Shibata, MD, Nobuhiko Nakamura, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2015) 126 (23): 1515.

https://doi.org/10.1182/blood.V126.23.1515.1515

Published: 2015

Journal Articles

Combination Of Indoleamine 2,3-Dioxygenase Inhibitor and Cytotoxic Agents Is a Novel Therapeutic Option For Non-Hodgkin Lymphoma

Nobuhiko Nakamura, MD, Takeshi Hara, MD, PhD, Yuhei Shibata, MD, Takuro Matsumoto, MD, Ryoko Mabuchi, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD, PhD, Nobuhiro Kanemura, MD, PhD, Naoe Goto, MD, PhD, Masahito Shimizu, MD, PhD, Hisashi Tsurumi, MD, PhD, Hisataka Moriwaki

Blood (2013) 122 (21): 4408.

https://doi.org/10.1182/blood.V122.21.4408.4408

Published: 2013

Journal Articles

Tryptophan Catabolism Is Associated with Clinical Outcome of Patients with Malignant Lymphoma

Soranobu Ninomiya, MD, Hisashi Tsurumi, MD, PhD, Takeshi Hara, MD, PhD, Masato Hoshi, Naoe Goto, MD, PhD, Nobuhiro Kanemura, MD, PhD, Senji Kasahara, MD, PhD, Masahito Shimizu, MD, PhD, Kuniaki Saito, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 4146.

https://doi.org/10.1182/blood.V116.21.4146.4146

Published: 2010

Journal Articles

The Immunohistochemical Pattern of Indoleamine 2,3-Dioxygenase in Tumor Tissue Indicates the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Soranobu Ninomiya, Nobuhiro Kanemura, Hisashi Tsurumi, MD, PhD, Takeshi Hara, Naoe Goto, Takeshi Yoshikawa, Senji Kasahara, Masahito Shimizu, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2009) 114 (22): 2924.

https://doi.org/10.1182/blood.V114.22.2924.2924

Published: 2009

Journal Articles

Synergistic Growth Inhibition by the Combination of Acyclic Retinoid Plus Vitamin K 2 in HL-60 Cells

Junichi Kitagawa, Senji Kasahara, Takeshi Hara, Nobuhiro Kanemura, Masahito Shimizu, Hisashi Tsurumi, MD, PhD, Hisataka Moriwaki

Blood (2008) 112 (11): 5027.

https://doi.org/10.1182/blood.V112.11.5027.5027

Published: 2008

Journal Articles

Priming Effect with G-CSF Enhances In Vitro Apoptosis by Treatment with Ara-C and VP-16 in Leukemic Cell Line.

Jun-ichi Kitagawa, Takeshi Hara, Hisashi Tsurumi, Nobuhiro Kanemura, Masahito Shimizu, Hisataka Moriwai

Blood (2007) 110 (11): 4333.

https://doi.org/10.1182/blood.V110.11.4333.4333

Published: 2007

Journal Articles

The Combination of 9-cis Retinoic Acid Plus MEK Inhibitor Induces Apoptosis Via Dephosphorylation of Retinoid X Receptor α in HL-60R Cells.

Nobuhiro Kanemura, MD, Hisashi Tsurumi, MD, Senji Kasahara, MD, Takeshi Hara, MD, Toshiki Yamada, MD, Masahito Shimizu, MD, Hisataka Moriwaki, MD

Blood (2006) 108 (11): 1927.

https://doi.org/10.1182/blood.V108.11.1927.1927

Published: 2006

NARROW

Real-World Experience of Pola-R-CHP Therapy in Diffuse Large B-Cell Lymphoma Aged 80 or Older

Prognostic Impact of Skeletal Muscle Index and Vitamin D in Diffuse Large B-Cell Lymphoma

The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Elderly Patients with Diffuse Large B-Cell Lymphoma

Prospective PhaseⅡ Study of Reduced Toxicity Conditioning Consisted of High Dose-Cytarabine, Fludarabine, Cyclophosphamide +/- Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation

The Roles of Aryl Hydrocarbon Receptor in T Cells at IDO-Positive Tumor Microenvironment

Benefit of Consolidative Radiotherapy in Patients with Limited Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era

The Value of Combination of Serum L-Kynurenine Level and Expression of Indoleamine 2,3-Dioxygenase mRNA As a Prognostic Factor in Acute Myeloid Leukemia

Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia

The Incidence and the Risk Factors of Bowel Perforation Due to Chemotherapy in Gastrointestinal Diffuse Large B Cell Lymphoma

Combination Of Indoleamine 2,3-Dioxygenase Inhibitor and Cytotoxic Agents Is a Novel Therapeutic Option For Non-Hodgkin Lymphoma

Tryptophan Catabolism Is Associated with Clinical Outcome of Patients with Malignant Lymphoma

The Immunohistochemical Pattern of Indoleamine 2,3-Dioxygenase in Tumor Tissue Indicates the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Synergistic Growth Inhibition by the Combination of Acyclic Retinoid Plus Vitamin K 2 in HL-60 Cells

Priming Effect with G-CSF Enhances In Vitro Apoptosis by Treatment with Ara-C and VP-16 in Leukemic Cell Line.

The Combination of 9-cis Retinoic Acid Plus MEK Inhibitor Induces Apoptosis Via Dephosphorylation of Retinoid X Receptor α in HL-60R Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only